We are happy to announce that our long-term client and trusted partner, Greene Street Pharmaceuticals LLC, strengthened our business relationship today by appointing us as their exclusive API sourcing partner.

The Pennsylvania-based company specializes in #transdermal delivery systems with the vision to make a meaningful impact on patients’ lives. Greene Street utilizes Quinta-Analytica’s API Solution services for multiple projects and is able to leverage the partnership to ensure a high level of continuity and expand their offering beyond the scope of their core service provision.

This is yet another recognition of Quinta’s world-class API Solutions program, which supports partners from all geographies and backgrounds with our robust services – now and into the future!

Additional News

  • 18 July 2023

    Challenges of a large-scale study of breast cancer

    Our bioanalytical experts and a high-profile client team up for the development of a new therapy for breast cancer.

  • 29 June 2023

    EU funding for Quinta-Analytica laboratory in Brno (CZ) was succesfully completed.

    After two years, the project to finance new equipment for the Quinta-Analytica laboratory in Brno was successfully completed. The investment from European Regional Development Fund was used in this project.

  • 22 June 2023

    Quinta Analytica Partners with EvidentIQ to Enhance Efficiency of Phase 1 Studies

    EvidentIQ partners with Quinta-Analytica to enhance Phase 1 study efficiency